Literature DB >> 2189625

Serological and immunohistochemical determination of von Willebrand factor antigen in serum and biopsy specimens from patients with arteritis temporalis and polymyalgia rheumatica.

A Olsson1, P Elling, H Elling.   

Abstract

Von Willebrand factor antigen (vWF-Ag) levels in serum from patients with untreated polymyalgia rheumatica (PMR) and arteritis temporalis (AT) were measured using an ELISA technique. The level in patients with AT was significantly higher (median 229%, range 182-358%) than in patients with PMR (median 190%, range 131-390%) and in controls (median 179%, range 65-296%). Using an immunoperoxidase technique and biopsy specimens from 21 temporal arteries (7 patients with AT, 7 with PMR and 7 with other diseases), vWF-Ag was localized in the luminal endothelium in all cases. VWF-Ag was also present in many new vessels along the lamina elastica of the artery wall in all patients with AT, but not in patients with PMR. We relate the higher vWF-Ag level in these patients to an increased vWF-Ag production by endothelian cells in new, proliferating vessels in the artery wall.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189625

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  Von Willebrand factor in the outcome of temporal arteritis.

Authors:  M C Cid; J Monteagudo; J Oristrell; J Vilaseca; L Pallarés; R Cervera; C Font; J Font; M Ingelmo; A Urbano-Márquez
Journal:  Ann Rheum Dis       Date:  1996-12       Impact factor: 19.103

2.  Endothelium damage and von Willebrand factor antigen.

Authors:  P Elling; A Olsson; H Elling
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

3.  Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.

Authors:  P L Lip; D C Felmeden; A D Blann; N Matheou; S Thakur; I A Cunliffe; G Y H Lip
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

4.  Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis.

Authors:  M C Cid; D S Grant; G S Hoffman; R Auerbach; A S Fauci; H K Kleinman
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.